Tranexamic Acid Benefits Total Joint Arthroplasty Patients Regardless of Preoperative Hemoglobin Value

Journal of Arthroplasty

Volumn 30, Issue 12, 2015, Pages 2098-2101

  Whiting, Daniel R ^a   Duncan, Christopher M ^a   Sierra, Rafael J ^a   Smith, Hugh M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Hemoglobin; THA; TKA; Total hip arthroplasty; Total knee arthroplasty; Tranexamic acid

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; ARTHROPLASTY; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HIP ARTHROPLASTY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SELECTION BIAS; THROMBOEMBOLISM; TOTAL JOINT ARTHROPLASTY; TOTAL KNEE REPLACEMENT; AGED; BLOOD LOSS, SURGICAL; HIP REPLACEMENT; KNEE REPLACEMENT; STATISTICS AND NUMERICAL DATA;

AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84952874887     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2015.05.050     Document Type: Article

References (29)

1. Bierbaum B., Callaghan J., Galante J., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999, 81:2.
2. Sehat K., Evans R., Newman J. Hidden blood loss following hip and knee arthroplasty. J Bone Joint Surg Br 2004, 86:561.
3. Alvarez J.C., Santiveri F.X., Ramos I., et al. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion 2008, 48:519.
4. Benoni G., Fredin H., Knebel R., et al. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand 2001, 72:442.
5. Camarasa M.A., Olle G., Serra-Prat M., et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth 2006, 96:576.
6. Cid J., Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 2005, 45:1302.
7. Engel J.M., Hohaus T., Ruwoldt R., et al. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg 2001, 92:775.
8. Gill J.B., Rosenstein A. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis. J Arthroplasty 2006, 21:869.
9. Henry D.A., Carless P.A., Moxey A.J., et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011, 16:CD001886.
10. Ho K.M., Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care 2003, 31:529.
11. Hynes M., Calder P., Scott G. The use of tranexamic acid to reduce blood loss during total knee arthroplasty. Knee 2003, 10:375.
12. Kagoma Y.K., Crowther M.A., Douketis J., et al. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009, 123:687.
13. Lemay E., Guay J., Cote C., et al. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth 2004, 51:31.
14. Murkin J.M., Haig G.M., Beer K.J., et al. Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement. J Bone Joint Surg Am 2000, 82:675.
15. Shiga T., Wajima Z., Inoue T., et al. Aprotinin in major orthopedic surgery: a systematic review of randomized controlled trials. Anesth Analg 2005, 101:1602.
16. Veien M., Sorensen J.V., Madsen F., et al. Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: a randomized, controlled study. Acta Anaesthesiol Scand 2002, 46:1206.
17. Yamasaki S., Masuhara K., Fuji T. Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty. J Bone Joint Surg Am 2005, 87:766.
18. Yang Z., Chen W., Wu L. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 2012, 94:1153.
19. Zohar E., Fredman B., Ellis M.H., et al. A comparative study of the postoperative allogeneic blood-sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion 2001, 41:1285.
20. Alshryda S., Mason J., Sarda P., et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Joint Surg Am 2013, 95:1969.
21. Alshryda S., Mason J., Vaghela M., et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). J Bone Joint Surg Am 2013, 95:1961.
22. Gillette B., Maradit Kremers H., Duncan C., et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arhtroplasty 2013, 28(8 Suppl.):137.
23. Jans O., Jorgensen C., Kehlet H., et al. Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Collaborative Group. Transfusion 2014, 54:717.
24. Larocque B., Gilbert K., Brien W. A point score system for predicting the likelihood of blood transfusion after hip or knee arthroplasty. Transfusion 1997, 37463.
25. Noticewala M., Nyce J., Wang W., et al. Predicting need for allogeneic transfusion after total knee arthroplasty. J Arthroplasty 2012, 27:961.
26. Ogbemudia A., Yee S., MacPherson G., et al. Preoperative predictors for allogenic blood ansfusion in hip and knee arthroplasty for rheumatoid arthritis. Arch Orthop Trauma Surg 2013, 133:1315.
27. Gillette B., DeSimone L., Trousdale R., et al. Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Clin Orthop Relat Res 2013, 471:150.
28. Klika A., Small T., Saleh A., et al. Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: nationwide inpatient sample 2000-2009. J Arthroplasty 2014, 29:2070.
29. Saleh A., Small T., Pillai A., et al. Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009. J Bone Joint Surg 2014, 96(1-10):e155.